Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Colorado for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Colorado only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Colorado (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Arthur Korotkin (NPI 1023166345)

Field	Value
Entity Type	Individual
Organization	Arthur Korotkin
Address	1725 E Prospect Rd
City	Fort Collins
State	CO
ZIP	80525
Taxonomy	Ophthalmology Physician
NPI Enumerated	January 5, 2007

Payer Source	Total Paid
Medicare	$3.7M
Medicaid	$0

Key Findings

This provider is an Ophthalmology Physician with a long active tenure (NPI enumerated 2007-01-05 (~19 years ago)) and a Medicare-focused billing footprint: lifetime Medicare revenue is $3.7M and there is no Medicaid billing on file, indicating an effectively single‑payer (Medicare) practice mix in the claims dataset. The absence of Medicaid activity suggests limited engagement with state Medicaid programs or that Medicaid patients are not billed under this provider’s NPI.

Revenue is highly concentrated in a small set of injection and retina codes: the precomputed top 3 codes account for 82.3% of this provider’s total Medicare revenue, driven primarily by J0178 ($2.2M, 60.3%), J2777 ($541.1K, 14.5%), and 67028 ($276.4K, 7.4%). This concentration signals a practice model where high-cost intraocular drug therapy and related intravitreal procedures dominate financial outcomes rather than office E/M visits or a broad mix of minor procedures.

J0178 (aflibercept) is the single largest revenue driver: 3.3K claims producing $2.2M in revenue and ranking #135 of 3204 providers nationally (96th percentile). That placement and the descriptor "notably above typical national volume" indicate this provider is a high-volume aflibercept injector compared with peers, making medical retina injection therapy a core service line.

While J2777 (faricimab) shows very large claim volume (18.7K claims) and meaningful revenue ($541.1K), its national rank (#575 of 2039, 72th percentile) is characterized as typical and unremarkable relative to peers. In practice this means the provider uses newer anti-VEGF/anti‑angiogenic agents at scale, but that pattern is not uniquely dense versus the national cohort for that specific code.

Procedure 67028 (intravitreal injection as an isolated or separate procedure) adds $276.4K (2.7K claims) and ranks #140 of 4255 providers nationally (97th percentile), described as "notably above typical national volume." Together with the high J0178 and J2777 activity, this confirms a workflow centered on frequent intravitreal therapeutics rather than primarily surgical retina practice.

Diagnostic imaging is also a strong relative activity: 92134 produced $103.6K across 3.1K claims and ranks #344 of 26868 providers nationally (99th percentile), labeled an "extreme outlier, far above typical national volume." High OCT/imaging volume supports a practice oriented to ongoing monitoring and frequent follow-up of retinal disease, consistent with chronic intravitreal treatment regimens.

The provider shows above-typical utilization of compounded and unclassified drug billing: J7999 ($89.1K, rank #37 of 1333, 97th percentile; "notably above typical") and J3490 ($179.8K, rank #1074 of 2838, 62th percentile) together account for a nontrivial share of non‑standard drug revenue. This mix suggests on-site or practice-managed medication compounding/use of miscellaneous drug billing in addition to standard branded injectables, which has implications for procurement, inventory, and drug-cost management.

Non-procedural office visits and surgical retina services constitute a modest portion of revenue: 99214 generated $85.5K (900 claims, rank #14842 of 479517, 97th percentile — "notably above typical"), while multiple surgical retina codes (e.g., 67042, 67036, 67108) appear at low claim counts and mid-to-lower national percentiles. Overall the pattern is clinical care concentrated on high-frequency intravitreal treatment and imaging with occasional higher-acuity surgical interventions, indicating a medically oriented retina practice rather than a predominantly surgical or general ophthalmology clinic.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

22 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	3,270	$690	$2.2M
J2777	Injection, faricimab‑svoa, 0.1 mg	18,660	$30	$541.1K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,660	$100	$276.4K
J3490	Unclassified drugs	80	$2,370	$179.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,140	$30	$103.6K
J2778	Injection, ranibizumab, 0.1 mg	500	$180	$90.7K
J7999	Compounded drug, not otherwise classified	1,170	$80	$89.1K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	900	$100	$85.5K
67042	In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina…	20	$920	$18.4K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	250	$60	$15.9K

Showing 1–10 of 22

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 22 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Colorado Distribution

Arthur Korotkin — 5 of 22 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Colorado

Full comparison — all codes billed, vs. state median

22 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	1	60	740	$690	$618.3K
J2777	12	40	8,910	$30	$456.1K
J2778	15	20	600	$180	$199.7K
67028	1	80	670	$100	$73.3K
67036	15	30	20	$1,100	$37.3K
67042	16	30	20	$1,140	$29.6K
67108	11	20	20	$1,260	$26.5K
J3490	17	60	50	$290	$23.1K
J7999	3	50	230	$70	$21.5K
67041	7	10	10	$1,260	$21.4K

Showing 1–10 of 22

Related Providers

Other providers that share a Tax Identification Number (TIN) with Arthur Korotkin, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ali Torab Parhiz	ID	Ophthalmology Physician	$4.3M	$7.8K
Douglas Holmes	WY	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Brittney Statler	CO	Ophthalmology Physician	$3.7M	$0
John Purviance	WY	Radiation Oncology Physician	$2.5M	$0
Cary Chisholm	TX	Anatomic Pathology & Clinical Pathology Physician	$2.5M	$24.7K
Matthew Asano	CO	Ophthalmology Physician	$2M	$0
Peter Hovland	CO	Ophthalmology Physician	$1.8M	$0
James Levine	CO	Rheumatology Physician	$1.7M	$0
Nora Muakkassa	CO	Ophthalmology Physician	$1.3M	$0
Navid Moradshahi	CA	Diagnostic Radiology Physician	$1.2M	$0

Nearby Providers

Other providers in the same ZIP code as Arthur Korotkin, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mosaic	CO	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$40.1M
Foothills Gateway Inc.	CO	In Home Supportive Care Agency	$0	$34.6M
Rocky Mountain Clinics LLC	CO	Clinical Medical Laboratory	$0	$13.1M
Foothills Gateway, Inc.	CO	Case Manager/Care Coordinator	$0	$10.8M
Svc Dental Group, LLC	CO	Pediatric Dentistry	$0	$8.4M
Summitstone Health Partners	CO	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$7.4M
The Residence At Oakridge, LLC	CO	Assisted Living Facility	$0	$6.9M
Fort Collins Radiologic Associates PC	CO	Diagnostic Radiology Physician	$0	$6.4M
Reyes Corporation	CO	Community/Behavioral Health Agency	$0	$5.2M
Highpointe Services	CO	Developmentally Disabled Services Day Training Agency	$0	$5.1M

Arthur Korotkin — Billing Profile & Reimbursement Data

Sign up for Arthur Korotkin — Billing Profile & Reimbursement Data policy alerts

Arthur Korotkin — Billing Profile & Reimbursement Data

Sign up for Arthur Korotkin — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References